Physician profile
Deepak Jaiswal
NPI 1386698728
$870.29
in general payments reported to CMS, 2019-2025
18 companies · $14.23 in 2025
The $14.23 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $181 · 2021: $91.42 · 2022: $180 · 2023: $128 · 2024: $155 · 2025: $14.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $274.98 | 2019-2024 | |
| Pfizer INC. | $156.93 | 2019-2022 | |
| Lilly USA, LLC | $70.58 | 2020-2025 | Mounjaro, Zepbound |
| Abbott Laboratories | $69.53 | 2019-2024 | Aveir |
| Indivior INC. | $53.06 | 2020-2023 | Sublocade |
| Glaxosmithkline, LLC. | $37.47 | 2020-2024 | Arexvy, Trelegy Ellipta |
| Analog Devices INC. | $25.78 | 2024 | Sensinel Cpm Wearable |
| Heartflow, INC. | $20.87 | 2024 | |
| Exact Sciences Corporation | $19.58 | 2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $19.12 | 2020 | |
| Genentech USA, INC. | $18.50 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.23 | 2019 | |
| Medtronic Vascular, INC. | $16.46 | 2020 | |
| Pear Therapeutics (US), INC. | $16.05 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.81 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $14.09 | 2019 | |
| Abbvie INC. | $13.46 | 2023 | |
| Novartis Pharmaceuticals Corporation | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Jaiswal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.